Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease

Mostrar otras versiones (1)

OBJECTIVE: To evaluate the impact of 3-tier (copayment) pharmacy benefit structures on medication utilization behavior. METHODS: A pretest-posttest quasi-experimental design was employed. Chronic disease sufferers (N=8,132) from a health plan were classified into the following groups: (a) 2-tier cop...

Descripción completa

Detalles Bibliográficos
Autores principales: NAIR, KAVITA V., WOLFE, PAMELA, VALUCK, ROBERT J., MCCOLLUM, MARIANNE M., GANTHER, JULIE M., LEWIS, SONYA J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Vintage Rerun
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390995/
https://www.ncbi.nlm.nih.gov/pubmed/32347176
http://dx.doi.org/10.18553/jmcp.2020.26.5.575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390995/
https://www.ncbi.nlm.nih.gov/pubmed/32347176
http://dx.doi.org/10.18553/jmcp.2020.26.5.575

Ejemplares similares